All News

Pharmacists are key to CGM education, but time, training, and reimbursement remain major barriers.

Researchers presented findings from a pharmacist-led pilot program for opioid deprescribing among patients in a palliative care clinic.

Through her work with Prosper Rx Consulting, Ashley Kay Pendrick, PharmD, discusses the expansion of pharmacists’ roles beyond medication dispensing.

Understanding post-PREP implications is critical for evaluating current public health delivery, identifying ongoing access, and informing future policy.

Kimberly Jones, RPh, shares how Austin Pharmacy & Medical Supplies combines pharmacy and medical supply services under one roof.

Compounding pharmacies help meet patient needs by formulating alternative versions in the face of drug shortages but are no longer allowed to compound them.

Although stroke is not common in pregnancy or childbearing years, pregnancy can increase the risk.

Searching for the clinical and economic impacts, researchers explored the implications of pharmacist-led anti-infective consultations.

Offering a glimpse into how social isolation and loneliness impact health outcomes, researchers explored how pharmacists promote social health care among their patients.

Colleges of pharmacy are retooling curricula and faculty skill sets to ensure students are prepared to use the technology of the next decade.

Less than 1 in 3 patients can very or extremely accurately predict when they will experience symptoms on a given day.

As researchers continue to measure the impacts of the COVID-19 pandemic on public health, Hashim Zaibak, PharmD, discusses the evolution of community pharmacies in a postpandemic world.

In an exploration of recent mothers across the US, researchers addressed the association of hypertensive disorders during pregnancy with breastfeeding and breastfeeding cessation.

In this episode of NCPDPunscripted, NCPDP sits down with Christian Tadrus, R.Ph, PharmaD, FASCP, AE-C, NSC and Mindy Smith. R.Ph, MHA, to talk about leadership, progress, and what’s next for NCPDP.

Investigators find modest improvements in body weight at week 26 for CT-868 compared with the placebo.

At 72 weeks, patients who took the highest dose of orforglipron lost an average of 27.3 lb.

With more than half the population struggling to access medical care, community pharmacies are emerging as unexpected heroes in the health care delivery system.

Pharmacists can now showcase their skills within the health care industry by counseling patients and continuing to learn and grow with them.

As part of a retrospective study, researchers explored the association between BMI and osteoporosis risk as outcomes evolve from adolescence to adulthood.

Sit-to-stand transitions may lower diastolic blood pressure in postmenopausal women with overweight or obesity, offering a simple way to reduce cardiovascular risk.

Researchers gathered a group of adolescent-serving clinicians and asked them about their confidence in helping patients with abortion access.

Fremanezumab-vfrm (Ajovy) receives FDA approval for the prevention of episodic migraine for patients aged 6 to 17 years.

New research shows metformin's inconsistent neuroprotective effects against Alzheimer disease, challenging its role in diabetes management for cognitive health.

Patients with type 2 diabetes and moderate cardiovascular risk had a higher rate of major heart-related events when treated with sulfonylureas.

Among rural community pharmacies in the US, researchers explored pneumococcal immunization services, the processes used to identify patient eligibility, and the barriers to vaccine administration.

FDA approves Biktarvy for HIV treatment in patients not virologically suppressed, enhancing options for those restarting antiretroviral therapy.

Researchers conducted a systematic review to determine the effectiveness of pharmacists in promoting vaccine uptake for protection against the most prominent infectious diseases.

After the certification of a new stroke center in respective communities, researchers compared the stroke outcomes of Black patients with those of White patients.

Since the COVID-19 pandemic, pharmacists are reevaluating career paths and calling for greater flexibility, support, and opportunities for professional growth.